193 related articles for article (PubMed ID: 3038208)
1. Epidemiological survey of HIV infection in the Veneto region of Italy.
Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O
Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208
[TBL] [Abstract][Full Text] [Related]
2. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
[TBL] [Abstract][Full Text] [Related]
4. HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy.
De Rossi A; Gassa OD; del Mistro A; Faulkner Valle G; Bianchi LC
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):411-8. PubMed ID: 3015630
[TBL] [Abstract][Full Text] [Related]
5. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis.
Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL
Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497
[TBL] [Abstract][Full Text] [Related]
6. Relationship between immunodeficiency conditions and AIDS-associated retrovirus (ARV) infection in homosexual men and i.v. drug abusers in the Campania Region.
Castello G; Melillo G; D'Alessio V; Leonardi E; Zarrilli D; Cataldo PT; Chirianni A; de Mercato R; Piazza M
Haematologica; 1986; 71(6):453-7. PubMed ID: 3104152
[No Abstract] [Full Text] [Related]
7. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
[TBL] [Abstract][Full Text] [Related]
8. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays.
Resnick L; Shapshak P
Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005
[TBL] [Abstract][Full Text] [Related]
9. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
10. The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera.
Filice G; Soldini L; Orsolini P; Campisi D; Chiesa A; Gulminetti R; Achilli G; Cattaneo E
Microbiologica; 1991 Jan; 14(1):9-13. PubMed ID: 2067417
[TBL] [Abstract][Full Text] [Related]
11. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
[TBL] [Abstract][Full Text] [Related]
12. LAV/HTLV-III neutralizing antibodies in the sera of patients with AIDS, lymphadenopathy syndrome and asymptomatic seropositive individuals.
Faulkner-Valle GP; De Rossi A; Dalla Gassa O; Chieco-Bianchi L
Tumori; 1986 Jun; 72(3):219-24. PubMed ID: 3016957
[TBL] [Abstract][Full Text] [Related]
13. HTLV-III infection in Canada in 1985.
Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
[TBL] [Abstract][Full Text] [Related]
14. [Detection of HTLV-III antibodies using ELISA and the western blot].
Kunz C; Heinz FX
Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046
[TBL] [Abstract][Full Text] [Related]
15. The spread of HIV-1 infection in Italy: seropositivity and AIDS related syndromes.
Luzi G; Greco D; Sasse H; Rezza G; Aiuti F
Allergol Immunopathol (Madr); 1991; 19(1):19-24. PubMed ID: 1950940
[TBL] [Abstract][Full Text] [Related]
16. [Acquired immunodeficiency syndrome (AIDS). An update after 4 years].
Vogt M; Lüthy R; Siegenthaler W
Schweiz Med Wochenschr; 1985 May; 115(19):665-71. PubMed ID: 2988117
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HIV infection in healthy subjects and groups of patients in Tanzania.
Mhalu F; Bredberg-Rådén U; Mbena E; Pallangyo K; Kiango J; Mbise R; Nyamuryekunge K; Biberfeld G
AIDS; 1987 Dec; 1(4):217-21. PubMed ID: 3126768
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.
Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A
Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis.
Weber JN; Clapham PR; Weiss RA; Parker D; Roberts C; Duncan J; Weller I; Carne C; Tedder RS; Pinching AJ
Lancet; 1987 Jan; 1(8525):119-22. PubMed ID: 2879968
[TBL] [Abstract][Full Text] [Related]
20. [AIDS: an assessment of the potential occupational risk in the dental environment for HIV (human immunodeficiency virus) infection].
Avoni A; Borea G; Chiodo F; Costigliola P; Ricchi E
Minerva Stomatol; 1986 Oct; 35(10):941-6. PubMed ID: 3467166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
